Wenjun Cheng

No ORCID on file · 7 papers in corpus · active 2009-2026

Study types

  • article 4
  • meta-analysis 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 4
  • endometrioma 1
  • adenomyosis 1
meta-analysis 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-025-02031-1

This systematic review and meta analysis was conducted to investigate the reproductive outcomes in the patients with adenomyosis after HIFU treatment, aimed to recommend HIFU treatment for those women with adenomyosis who have reproductive …

article 2024
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-023-05524-1

PURPOSE: The preoperative diagnosis of endometriosis associated ovarian cancer (EAOC) remains challenging for lack of effective diagnostic biomarker. We aimed to study clinical characteristics and develop a nomogram for diagnosing EAOC befo…

article 2023
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14695

OBJECTIVE: Endometriosis-associated ovarian cancer (EAOC) is difficult to diagnose because of its low incidence, uncertain risk factors, and the absence of effective markers. This study aimed to investigate the clinical characteristics of E…

preprint 2020
·doi:10.21203/rs.2.23832/v1

Abstract Background : Many studies have well supported the close relationship between miRNA and endometrial cancer (EC). This bioinformatic study, compared with other similar studies, confirmed a new miRNA-mRNA regulatory network to investi…

article 2018

Objective: To investigate the effects of suspension laparoscopy and pneumoperitoneum \nlaparoscopic surgery on inflammatory response, stress hormone and ovarian function in \npatients with ovarian cystectomy. Methods: Retrospective analysis…

review 2012
Annals of human genetics ·doi:10.1111/j.1469-1809.2012.00726.x

Published data on the association between the vascular endothelial growth factor (VEGF) gene -460C/T (rs833061), +405G/C (rs2010963), +936T/C (rs3025039) polymorphisms and endometriosis risk are inconclusive. Eleven eligible case-control st…

article 2009
Molecular immunology ·doi:10.1016/j.molimm.2009.04.014